Enumeration of CD34-positive Stem Cells Using the ADAMII Image-based Fluorescence Cell Counter
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: It is very important to accurately enumerate CD34-positive (CD34+) cells for successful hematopoietic stem cell transplantation (HSCT). We evaluated the ability of the newly developed image based-immunofluorescence cell counter ADAMII (NanoEntek, Seoul, Korea) to enumerate CD34+ cells, which was improved through simultaneous CD45 analysis. Methods: We enumerated CD34+ cells with ADAMII using 19 peripheral blood (PB) and 91 leukapheresis samples from HSCT donors. Analytical performance, including precision and linearity, was analyzed, and sample stability during storage was evaluated. Viable CD34+ cell count (vCD34) and viable CD45+ cell count (vCD45) and the percentage of viable CD34+ cells among viable CD45+ cells (CD34/CD45) as measured by ADAMII were compared with the corresponding values from two flow cytometry assays, using regression analysis. Results: ADAMII demonstrated acceptable precision, as CV values of vCD34 from six samples with different counts were all <10% (range: 3.49–9.51%). CV values of the vCD45 and CD34/45 ranged from 4.03% to 9.67% and from 2.48% to 10.07%, respectively. The linearity of vCD34 showed an excellent R2 value (0.99) when analyzed using the intended count and flow cytometry data. The ADAMII and two flow cytometry-based assays generated very similar data for the PB and leukapheresis samples. Conclusions: ADAMII demonstrated excellent performance for use as a routine clinical assay in terms of CD34+ cell enumeration from PB and leukapheresis samples. Moreover, it could be used as a point-of-care-test for determining mobilization time and predicting an adequate apheresis stem cell product.
Abstract
Background: It is very important to accurately enumerate CD34-positive (CD34+) cells for successful hematopoietic stem cell transplantation (HSCT). We evaluated the ability of the newly developed image based-immunofluorescence cell counter ADAMII (NanoEntek, Seoul, Korea) to enumerate CD34+ cells, which was improved through simultaneous CD45 analysis. Methods: We enumerated CD34+ cells with ADAMII using 19 peripheral blood (PB) and 91 leukapheresis samples from HSCT donors. Analytical performance, including precision and linearity, was analyzed, and sample stability during storage was evaluated. Viable CD34+ cell count (vCD34) and viable CD45+ cell count (vCD45) and the percentage of viable CD34+ cells among viable CD45+ cells (CD34/CD45) as measured by ADAMII were compared with the corresponding values from two flow cytometry assays, using regression analysis. Results: ADAMII demonstrated acceptable precision, as CV values of vCD34 from six samples with different counts were all <10% (range: 3.49–9.51%). CV values of the vCD45 and CD34/45 ranged from 4.03% to 9.67% and from 2.48% to 10.07%, respectively. The linearity of vCD34 showed an excellent R2 value (0.99) when analyzed using the intended count and flow cytometry data. The ADAMII and two flow cytometry-based assays generated very similar data for the PB and leukapheresis samples. Conclusions: ADAMII demonstrated excellent performance for use as a routine clinical assay in terms of CD34+ cell enumeration from PB and leukapheresis samples. Moreover, it could be used as a point-of-care-test for determining mobilization time and predicting an adequate apheresis stem cell product.
참고문헌 (21)
- Bensinger WI, "Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor", Stem Cells, 14, pp.90~105 (1996)
- Schmitz N, "Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim(granulocyte colony-stimulating factor)", Blood, 85, pp.1666~1672 (1995)
- Bender JG, "Defining a therapeutic dose of peripheral blood stem cells", J Hematother, 1, pp.329~341 (1992)
- Lie AK, "Peripheral blood stem cells : transplantation and beyond", Oncologist, 2, pp.40~49 (1997)
- Massin F, "Validation of a single-platform method for hematopoietic CD34+ stem cells enumeration according to accreditation procedure", Biomed Mater Eng, 25(S1), pp.27~39 (2015)
- Allan DS, "Number of viable CD34(+)cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation", Bone Marrow Transplant, 29, pp.967~972 (2002)
- Noga SJ, "Using point-of-care CD34 enumeration to optimize PBSC collection conditions", Cytotherapy, 3, pp.11~18 (2001)
- Gigant C, "Quantitative expression of adhesion molecules on granulocyte colony-stimulating factor-mobilized peripheral blood, bone marrow, and cord blood CD34+ cells", J Hematother Stem Cell Res, 10, pp.807~814 (2001)
- Barnett D, "Guideline for the flow cytometric enumeration of CD34+ haematopoietic stem cells. Prepared by the CD34+ haematopoietic stem cell working party. General Haematology Task Force of the British Committee for Standards in Haematology", Clin Lab Haematol, 21, pp.301~308 (1999)
- Keeney M, "Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering", Cytometry, 34, pp.61~70 (1998)
- Sutherland DR, "The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering", J Hematother, 5, pp.213~226 (1996)
- Sutherland DR, "Comparison of two single-platform ISHAGE-based CD34 enumeration protocols on BD FACSCalibur and FACSCanto flow cytometers", Cytotherapy, 11, pp.595~605 (2009)
- CLSI, "Evaluation of precision performance of quantitative measurement methods, CLSI EP5-A2", Clinical and Laboratory Standards Institute, ~ (2004)
- CLSI, "Evaluation of the linearity of quantitative measurement procedures: a statistical approach CLSI EP6-A", Clinical and Laboratory Standards Institute, ~ (2003)
- Dietz LJ, "Volumetric capillary cytometry : a new method for absolute cell enumeration", Cytometry, 23, pp.177~186 (1996)
- Olivero S, "CD34+ cell enumeration in peripheral blood and apheresis samples, using two laboratory diagnostic kits or an institutional protocol", Bone Marrow Transplant, 23, pp.387~394 (1999)
- Chapple P, "Comparison of three methods of CD34+ cell enumeration in peripheral blood : dual-platform ISHAGE protocol versus single-platform, versus microvolume fluorimetry", Cytotherapy, 2, pp.371~376 (2000)
- Cho MO, "Performance evaluation of an automated image-based fluorescence CD4+ cell analyzer", Technol Health Care, 26, pp.867~871 (2018)
- Lane TA, "Improving the efficiency of PBPC collection by pre-apheresis peripheral blood and mid-apheresis product measurements of CD34 cells", Cytotherapy, 6, pp.318~327 (2004)
- Sidhu RS, "Midpoint CD34 measurement as a predictor of PBPC product yield in pediatric patients undergoing high-dose chemotherapy", J Clin Apher, 21, pp.165~168 (2006)
- Julie Chepovetsky SCY, "Roles of Peripheral Blood CD34+ Cell Count and Midpoint Collection CD34+ Cell Yield for Peripheral Blood Stem Cell Collections from Autologous Patients Mobilized by G-CSF and Plerixafor", North American Journal of Medicine and Science, 6, pp.63~70 (2013)